相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
Paracrine IL-6 Signaling Confers Proliferation between Heterogeneous Inflammatory Breast Cancer Sub-Clones
Riley J. Morrow et al.
CANCERS (2022)
Tocilizumab overcomes chemotherapy resistance in mesenchymal stem-like breast cancer by negating autocrine IL-1A induction of IL-6
Andrew W. Chung et al.
NPJ BREAST CANCER (2022)
Targeting the IL-6/STAT3 Signalling Cascade to Reverse Tamoxifen Resistance in Estrogen Receptor Positive Breast Cancer
Ho Tsoi et al.
CANCERS (2021)
Cytokines in various molecular subtypes of breast cancer
Alexsander Autenshlyus et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2021)
Translating IL-6 biology into effective treatments
Ernest H. Choy et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer Metastasis
Rasmus Siersbaek et al.
CANCER CELL (2020)
Interleukin-6 and interleukin-8 serum levels in prognosis of hormone-dependent breast cancer
Jelena Milovanovic et al.
CYTOKINE (2019)
C/EBPδ links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes
Kuppusamy Balamurugan et al.
ONCOGENE (2019)
Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer
Jilai Tian et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Interleukin 6 signaling maintains the stem-like properties of bladder cancer stem cells
Hua Wei
TRANSLATIONAL CANCER RESEARCH (2019)
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Florian R. Greten et al.
IMMUNITY (2019)
Targeting the Interplay Between Cancer Fibroblasts, Mesenchymal Stem Cells, and Cancer Stem Cells in Desmoplastic Cancers
Tze-Sian Chan et al.
FRONTIERS IN ONCOLOGY (2019)
Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection
Martina Biggioggero et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
IL-6 Triggers the Migration and Invasion of Oestrogen Receptor-Negative Breast Cancer Cells via Regulation of Hippo Pathways
Lingmi Hou et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2018)
STAT3 activation by IL-6 from adipose-derived stem cells promotes endometrial carcinoma proliferation and metastasis
Yijing Chu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Cancer-Associated Fibroblasts Affect Intratumoral CD8+ and FoxP3+ T Cells Via IL6 in the Tumor Microenvironment
Takuya Kato et al.
CLINICAL CANCER RESEARCH (2018)
Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2
Joao Incio et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Interleukin-6 receptor inhibitor suppresses bone metastases in a breast cancer cell line
Hiroki Wakabayashi et al.
BREAST CANCER (2018)
IL-6-mediated cross-talk between human preadipocytes and ductal carcinoma in situ in breast cancer progression
Hoe Suk Kim et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Serum amyloid A - a review
George H. Sack
MOLECULAR MEDICINE (2018)
Do We Know Jack About JAK? A Closer Look at JAK/STAT Signaling Pathway
Emira Bousoik et al.
FRONTIERS IN ONCOLOGY (2018)
Blocking Interleukin-6 and Interleukin-8 Signaling Inhibits Cell Viability, Colony-forming Activity, and Cell Migration in Human Triple-negative Breast Cancer and Pancreatic Cancer Cells
Shengling Fu et al.
ANTICANCER RESEARCH (2018)
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
Ali Masjedi et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Adipocyte-derived IL-6 and leptin promote breast Cancer metastasis via upregulation of Lysyl Hydroxylase-2 expression
Jin-Yong He et al.
CELL COMMUNICATION AND SIGNALING (2018)
Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis
Kideok Jin et al.
BREAST CANCER RESEARCH (2018)
IL6 blockade potentiates the anti-tumor effects of γ-secretase inhibitors in Notch3-expressing breast cancer
Dong Wang et al.
CELL DEATH AND DIFFERENTIATION (2018)
IL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patients
Narmeen Ahmad et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
IL-6, IL-8 and TNF-α levels correlate with disease stage in breast cancer patients
Yunfeng Ma et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2017)
Liposomal Nanoparticles Carrying anti-IL6R Antibody to the Tumour Microenvironment Inhibit Metastasis in Two Molecular Subtypes of Breast Cancer Mouse Models
Chunlei Guo et al.
THERANOSTICS (2017)
Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line
Paola Ortiz-Montero et al.
CELL COMMUNICATION AND SIGNALING (2017)
Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals
Shuwei Liang et al.
CANCER LETTERS (2017)
Interleukin-6 receptor in spindle-shaped stromal cells, a prognostic determinant of early breast cancer
Vivian Labovsky et al.
TUMOR BIOLOGY (2016)
IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections
Jeroen Slaats et al.
PLOS PATHOGENS (2016)
Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-ocpositive breast cancer
Tineke Casneuf et al.
BREAST CANCER-TARGETS AND THERAPY (2016)
Cancer-mediated adipose reversion promotes cancer cell migration via IL-6 and MCP-1
Kaoru Fujisaki et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Cancer Cachexia, Recent Advances, and Future Directions
Marie-France Penet et al.
CANCER JOURNAL (2015)
Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment
Pu Li et al.
CELL RESEARCH (2015)
Identification of therapeutic targets for breast cancer using biological informatics methods
Xuejian Liu et al.
MOLECULAR MEDICINE REPORTS (2015)
Interleukin-6 as a prognostic marker for breast cancer: a meta-analysis
ShuChen Lin et al.
TUMORI JOURNAL (2015)
Analysis of gene expression of secreted factors associated with breast cancer metastases in breast cancer subtypes
Elana J. Fertig et al.
SCIENTIFIC REPORTS (2015)
Systemic Inflammation in Cachexia - Is Tumor Cytokine Expression Profile the Culprit?
Emidio M. de Matos-Neto et al.
FRONTIERS IN IMMUNOLOGY (2015)
Interleukin-6 as a prognostic marker for breast cancer: a meta-analysis
ShuChen Lin et al.
TUMORI JOURNAL (2015)
Sphingosine kinase 1 contributes to leptin-induced STAT3 phosphorylation through IL-6/gp130 transactivation in oestrogen receptor-negative breast cancer
Heba Alshaker et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Gene expression profiling of histologically normal breast tissue in females with human epidermal growth factor receptor 2-positive breast cancer
Pavol Zubor et al.
MOLECULAR MEDICINE REPORTS (2015)
SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model
G. Kim et al.
ONCOGENE (2015)
An IL6-STAT3 loop mediates resistance to PI3K inhibitors by inducing epithelial-mesenchymal transition and cancer stem cell expansion in human breast cancer cells
Lin Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort
Andrea Markkula et al.
BMC CANCER (2014)
Adipocyte Lipolysis-stimulated Interleukin-6 Production Requires Sphingosine Kinase 1 Activity
Wenliang Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The Cytokine IL-6 Reactivates Breast Stromal Fibroblasts through Transcription Factor STAT3-dependent Up-regulation of the RNA-binding Protein AUF1
Siti-Fauziah Hendrayani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Drug Design Targeting Protein-Protein Interactions (PPIs) Using Multiple Ligand Simultaneous Docking (MLSD) and Drug Repositioning: Discovery of Raloxifene and Bazedoxifene as Novel Inhibitors of IL-6/GP130 Interface
Huameng Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
IL-6 in Inflammation, Immunity, and Disease
Toshio Tanaka et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
Association between adjuvant regional radiotherapy and cognitive function in breast cancer patients treated with conservation therapy
Osamu Shibayama et al.
CANCER MEDICINE (2014)
Suppression of elevations in serum C reactive protein levels by anti-IL-6 autoantibodies in two patients with severe bacterial infections
Toshihiro Nanki et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Cancer Associated Fibroblasts express pro-inflammatory factors in human breast and ovarian tumors
Neta Erez et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers
Chi-Chen Hong et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
The role of intratumoral and systemic IL-6 in breast cancer
Christine Dethlefsen et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8
Zachary C. Hartman et al.
CANCER RESEARCH (2013)
Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells
Seog-Young Kim et al.
CELLULAR SIGNALLING (2013)
Impact of LIF (leukemia inhibitory factor) expression in malignant melanoma
Silke Kuphal et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2013)
Peroxiredoxin V selectively regulates IL-6 production by modulating the Jak2-Stat5 pathway
Hoon-In Choi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Constitutive Activation of Signal Transducer and Activator of Transcription 3 (STAT3) and Nuclear Factor κB Signaling in Glioblastoma Cancer Stem Cells Regulates the Notch Pathway
Jo Meagan Garner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Early role for IL-6 signalling during generation of induced pluripotent stem cells revealed by heterokaryon RNA-Seq
Jennifer J. Brady et al.
NATURE CELL BIOLOGY (2013)
Interleukin-6 Mediates Epithelial-Stromal Interactions and Promotes Gastric Tumorigenesis
Hiroto Kinoshita et al.
PLOS ONE (2013)
Prognostic Role of Interleukin-6, Interleukin-8, and Leptin Levels According to Breast Cancer Subtype
Young Ae Cho et al.
CANCER RESEARCH AND TREATMENT (2013)
Interleukin-6 signaling pathway in targeted therapy for cancer
Yuqi Guo et al.
CANCER TREATMENT REVIEWS (2012)
Blockade of interleukin-6 receptor suppresses the proliferation of H460 lung cancer stem cells
Hee Yi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+Breast Cancer by Expanding the Cancer Stem Cell Population
Hasan Korkaya et al.
MOLECULAR CELL (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Satellite Cells Derived from Obese Humans with Type 2 Diabetes and Differentiated into Myocytes In Vitro Exhibit Abnormal Response to IL-6
Camilla Scheele et al.
PLOS ONE (2012)
LIF-Dependent Signaling: New Pieces in the Lego
Marie-Emmanuelle Mathieu et al.
STEM CELL REVIEWS AND REPORTS (2012)
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Juergen Scheller et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Formation, recognition and bioactivities of a novel G-quadruplex in the STAT3 gene
Sen Lin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells
Nilay Sethi et al.
CANCER CELL (2011)
Bone Marrow-Derived Myofibroblasts Contribute to the Mesenchymal Stem Cell Niche and Promote Tumor Growth
Michael Quante et al.
CANCER CELL (2011)
Breast Cancer Stem Cells Are Regulated by Mesenchymal Stem Cells through Cytokine Networks
Suling Liu et al.
CANCER RESEARCH (2011)
STAT3 Is Necessary for Proliferation and Survival in Colon Cancer-Initiating Cells
Li Lin et al.
CANCER RESEARCH (2011)
Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients
Praveen Ravishankaran et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2011)
Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study
Kristine H. Allin et al.
BREAST CANCER RESEARCH (2011)
A novel small-molecule inhibitor of IL-6 signalling
Giovanna Zinzalla et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Inflammation-mediated promotion of invasion and metastasis
Graziella Solinas et al.
CANCER AND METASTASIS REVIEWS (2010)
The Canonical NF-κB Pathway Governs Mammary Tumorigenesis in Transgenic Mice and Tumor Stem Cell Expansion
Manran Liu et al.
CANCER RESEARCH (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Myeloid-derived suppressor cell heterogeneity and subset definition
Elisa Peranzoni et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells
Frederic R. Santer et al.
ENDOCRINE-RELATED CANCER (2010)
Interleukin-6 in bone metastasis and cancer progression
Tasnim Ara et al.
EUROPEAN JOURNAL OF CANCER (2010)
IL-6: Regulator of Treg/Th17 balance
Akihiro Kimura et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
Christophe Ginestier et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Epigenetic control of the basal-like gene expression profile via Interleukin-6 in breast cancer cells
Laura D'Anello et al.
MOLECULAR CANCER (2010)
STAT3 Activation of miR-21 and miR-181b-1 via PTEN and CYLD Are Part of the Epigenetic Switch Linking Inflammation to Cancer
Dimitrios Iliopoulos et al.
MOLECULAR CELL (2010)
Generation of pathogenic TH17 cells in the absence of TGF-β signalling
Kamran Ghoreschi et al.
NATURE (2010)
Alterations in the Th1/Th2 balance in breast cancer patients using reflexology and scalp massage
Victoria L. Green et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2010)
Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation
Kenneth Leslie et al.
BREAST CANCER RESEARCH (2010)
An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation
Dimitrios Iliopoulos et al.
CELL (2009)
Elevated Biomarkers of Inflammation Are Associated With Reduced Survival Among Breast Cancer Patients
Brandon L. Pierce et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
IL-6 Is Required for Airway Mucus Production Induced by Inhaled Fungal Allergens
Wendy A. Neveu et al.
JOURNAL OF IMMUNOLOGY (2009)
The diseasome of physical inactivity - and the role of myokines in muscle-fat cross talk
Bente K. Pedersen
JOURNAL OF PHYSIOLOGY-LONDON (2009)
Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells
M. Walter et al.
ONCOGENE (2009)
Cancer Associated Fibroblasts Promote Tumor Growth and Metastasis by Modulating the Tumor Immune Microenvironment in a 4T1 Murine Breast Cancer Model
Debbie Liao et al.
PLOS ONE (2009)
Novel STAT3 Target Genes Exert Distinct Roles in the Inhibition of Mesoderm and Endoderm Differentiation in Cooperation with Nanog
Pierre-Yves Bourillot et al.
STEM CELLS (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Breast cancer care in India: The current scenario and the challenges for the future
Gaurav Agarwal et al.
BREAST CARE (2008)
Autocrine IL-6 signaling: A key event in tumorigenesis?
Sergei Grivennikov et al.
CANCER CELL (2008)
Serum insulin-like growth factor-I and platelet-derived growth factor as biomarkers of breast cancer prognosis
Patrizia Pasanisi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
The Interleukin-8 Pathway in Cancer
David J. J. Waugh et al.
CLINICAL CANCER RESEARCH (2008)
Cutting edge: Soluble IL-6R is produced by IL-6R ectodomain shedding in activated CD4 T cells
Eva M. Briso et al.
JOURNAL OF IMMUNOLOGY (2008)
IL-6 regulates neutrophil trafficking during acute inflammation via STAT3
Ceri A. Fielding et al.
JOURNAL OF IMMUNOLOGY (2008)
The wolf in sheep's clothing: the role of interieukin-6 in immunity, inflammation and cancer
Willscott E. Naugler et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Is obesity an independent prognosis factor in woman breast cancer?
Bilal Majed et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland
Pasquale Sansone et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas
Sizhi Paul Gao et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Antoine E. Karnoub et al.
NATURE (2007)
Plasma levels of interleukin-6 and C-reactive protein are associated with physical inactivity independent of obesity
C. P. Fischer et al.
SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS (2007)
Spectrum of breast cancer in Asian women
Gaurav Agarwal et al.
WORLD JOURNAL OF SURGERY (2007)
Evaluation of the relationship between the systemic inflammatory response and cancer-specific survival in patients with primary operable breast cancer
A. M. Al Murri et al.
BRITISH JOURNAL OF CANCER (2007)
Oestrogen receptor negative breast cancers exhibit high cytokine content
Carine Chavey et al.
BREAST CANCER RESEARCH (2007)
Interleukin-6 and its receptor: from bench to bedside
Juergen Scheller et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2006)
Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806
Mercedes Rincon et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Signals mediated by transforming growth factor-β initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease
Marc Veldhoen et al.
NATURE IMMUNOLOGY (2006)
Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer
Stefan Rose-John et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Interleukin-6: discovery of a pleiotropic cytokine
Tadamitsu Kishimoto
ARTHRITIS RESEARCH & THERAPY (2006)
Interleukin-6 and chronic inflammation
Cem Gabay
ARTHRITIS RESEARCH & THERAPY (2006)
Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer
AM Al Murri et al.
BRITISH JOURNAL OF CANCER (2006)
Exploiting the PI3K/AKT pathway for cancer drug discovery
BT Hennessy et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
The role of IL-6 and STAT3 in inflammation and cancer
DR Hodge et al.
EUROPEAN JOURNAL OF CANCER (2005)
Estrogen receptor inhibits interleukin-6 gene expression by disruption of nuclear factor κB transactivation
H Liu et al.
CYTOKINE (2005)
IL-6, its receptors and its relationship with bcl-2 and bax proteins in infiltrating and in situ human breast carcinoma
I Garcia-Tuñón et al.
HISTOPATHOLOGY (2005)
The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer
DJ McKeown et al.
BRITISH JOURNAL OF CANCER (2004)
Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling
R Clarke et al.
ONCOGENE (2003)
Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6
G Jego et al.
IMMUNITY (2003)
Serum interleukin-6 levels reflect the disease status of colorectal cancer
YC Chung et al.
JOURNAL OF SURGICAL ONCOLOGY (2003)
Circulating interleukin-6 predicts survival in patients with metastatic breast cancer
R Salgado et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Structure of the extracellular domains of the human interleukin-6 receptor α-chain
JN Varghese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Interleukin-6, tumour necrosis factor α and interleukin-1β in patients with renal cell carcinoma
N Yoshida et al.
BRITISH JOURNAL OF CANCER (2002)
Helicobacter pylori infection and the development of gastric cancer.
N Uemura et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
IL-6-like cytokines and cancer cachexia - Consequences of chronic inflammation
BE Barton
IMMUNOLOGIC RESEARCH (2001)
Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1
S Diehl et al.
IMMUNITY (2000)
分享论文
